September 6, 2013
Otsuka Holdings said on September 5 that its subsidiary Otsuka Pharmaceutical agreed on the same day to buy US biotech venture Astex Pharmaceuticals for about US$886 million, as Otsuka looks to beef up its cancer product pipeline and drug discovery...read more